Trials / Completed
CompletedNCT04559061
Vektor vMap™ Clinical Validation Study
Clinical Validation of the Vektor Computational ECG Mapping System (vMap™) for Atrial and Ventricular Arrhythmias/Pacing
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 225 (actual)
- Sponsor
- Vektor Medical · Industry
- Sex
- All
- Age
- 22 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
This is a retrospective, multi center clinical study collecting existing, de-identified subject data from medical records to be analyzed using an independent core laboratory to validate performance of a computational ECG mapping system (vMap™).
Conditions
- Cardiac Arrhythmia
- Atrial Fibrillation
- Ventricular Arrythmia
- Premature Ventricular Complexes Multiple
- Ventricular Tachycardia
- Ventricular Fibrillation
- Premature Atrial Complex
- Atrioventricular Reentrant Tachycardia
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Cardiac ablation procedure | Retrospective data will be collected from cases where successful ablation was completed. |
Timeline
- Start date
- 2020-12-01
- Primary completion
- 2021-04-06
- Completion
- 2021-04-06
- First posted
- 2020-09-22
- Last updated
- 2021-04-08
Locations
4 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04559061. Inclusion in this directory is not an endorsement.